Karl Egerer
Charité - Universitätsmedizin Berlin(DE)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Monoclonal and Polyclonal Antibodies Research, Systemic Lupus Erythematosus Research, Ubiquitin and proteasome pathways, Systemic Sclerosis and Related Diseases
Most-Cited Works
- → Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients(2009)447 cited
- → Elevated soluble CD14 receptors and altered cytokines in chronic heart failure(1997)394 cited
- → Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis(2007)291 cited
- → Rheumatoid factor revisited(2004)233 cited
- → Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study(2012)186 cited
- → Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma(2006)127 cited
- → Hyperprocalcitonemia in Patients with Noninfectious SIRS and Pulmonary Dysfunction Associated with Cardiopulmonary Bypass(1998)126 cited
- Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases.(2002)
- → Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests(2010)112 cited
- → Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus(2000)111 cited